Prostate cancer is one of the most common cancers in males, with about one man in nine to be diagnosed during his lifetime, according to the American Cancer Society.
Prostate cancer is one of the most common cancers in males, with about one man in nine to be diagnosed during his lifetime, according to the American Cancer Society.
While risk for the disease increases with age, genetics can play a role, too. More than 12 percent of men with prostate cancer tested positive for hereditary mutations of cancer-causing genes, according to study results presented at the 2018 Genitourinary Cancers Symposium. In particular, gene mutations can include BRCA, CHEK2, ATM and PALB2.
These genetic mutations may also have a role in treatment planning. For example, drugs such as PARP inhibitors are being looked at in the prostate cancer space.
Other treatment options for the disease include chemotherapy, radiation therapy and active surveillance — an option that one 2017 study said to be best for low-risk disease. However, the jury is still out on which patients should receive treatment and who should get active surveillance.
For more information on prostate cancer, visit curetoday.com/tumor/prostate.
A Prostate Cancer Researcher’s Unique Perspective as A Cancer Survivor
May 6th 2021In this episode of the “CURE® Talks Cancer” podcast, Leanne Burnham, Ph.D., discusses the research she’s working on to address health disparities in Black men with prostate cancer after being inspired by her father’s diagnosis, and shares her own cancer survival story.
Listen
There's Always Hope in Prostate Cancer
November 21st 2019On this week’s episode of the CURE Talks Cancer podcast, we talk with Grammy-winning songwriter and vocal producer Kuk Harrell about what it’s like to be “on the other side” of his prostate cancer diagnosis, and how he’s using his platform to shine a light on the disease.
Listen